Lamfers, M L M <br/><br/>
Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.  [electronic resource] 

 -  Circulation research  Nov 2002 
 - 945-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4571 
<br/><br/><label>Standard No.: </label>10.1161/01.res.0000041418.51906.57  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>CHO Cells--cytology<br/>Cell Division--drug effects<br/>Cell Membrane--metabolism<br/>Cell Movement--drug effects<br/>Cells, Cultured<br/>Cricetinae<br/>Culture Media, Conditioned--pharmacology<br/>Enzyme Activation--drug effects<br/>Flow Cytometry<br/>Gene Transfer Techniques<br/>Humans<br/>In Vitro Techniques<br/>Matrix Metalloproteinase 13<br/>Matrix Metalloproteinase Inhibitors<br/>Muscle, Smooth, Vascular--cytology<br/>Protein Structure, Tertiary--physiology<br/>RNA, Messenger--biosynthesis<br/>Receptors, Cell Surface--metabolism<br/>Receptors, Urokinase Plasminogen Activator<br/>Recombinant Fusion Proteins--biosynthesis<br/>Saphenous Vein--cytology<br/>Tissue Inhibitor of Metalloproteinase-1--genetics<br/>Tunica Intima--drug effects<br/>Urokinase-Type Plasminogen Activator--genetics